SYNJ1
protein-codingsynaptojanin 1, the group of Phosphoinositide phosphatases
Gene summary
This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~99.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014233
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014233
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0033362
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014233
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014233
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0017279
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018321
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0033362
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0100062
Submitter: ClinGen
SYNJ1 was first reported in relation to autosomal recessive Developmental Epileptic Encephalopathy (DEE) in 2015 (Dyment et al. 2015 PMID: 25316601). Besides DEE, SYNJ1 has been associated with autosomal recessive Parkinson disease, early onset. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found difference in phenotypes of these diseases. Therefore, the following disease entities have been split into two disease entities, Developmental and epileptic encephalopathy (OMIM:617389) and Parkinson disease, early onset (OMIM:615530). The split curation for autosomal recessive Parkinson disease, early onset may be curated by Parkinson disease GCEP. Eight SYNJ1 variants that have been reported in seven probands in five publications have been included in this curation. Typical phenotypes of these probands were neonatal onset seizures, hypotonia, severe to profound global developmental delay, and quadriplegia. Of the seven reported families, five had biallelic loss-of-function variants, and the default point of 1.5 was awarded for each allele, resulting in 15 points. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be LOF. This gene-disease association is also supported by an animal model (PMID: 10535736). The SYNJ1 knockout mice with seizures, failure to thrive, and ataxia, which manifest immediately after birth was given 2 points. In summary, SYNJ1 is definitively associated with autosomal recessive DEE. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0033362
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: Neurologic
Rationale: For Parkinson disease 20, response to levodopa has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SYNJ1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_203446.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 292 | 2 | 301 | ||
| missense | 2 | 2 | 517 | 26 | 2 | 549 |
| nonsense | 11 | 5 | 2 | 18 | ||
| start loss | 1 | 1 | ||||
| frameshift | 17 | 5 | 1 | 23 | ||
| splice donor/acceptor (+/-2bp) | 1 | 10 | 4 | 1 | 16 | |
| Total | 31 | 22 | 532 | 319 | 4 | 908 |
Highest pathogenic variant AF is 0.000011629148
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_982271.3 | 31 | MANE Select | |
| Ensembl | ENSP00000501530.1 | 31 | MANE Select | |
| RefSeq | NP_001153774.1 | 30 | Standard | |
| RefSeq | NP_001153778.1 | 27 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| synj1 | Danio rerio | Structure: neuromast hair cell Quality: amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Inositol phosphate metabolism - Homo sapiens (human)
- Phosphatidylinositol signaling system - Homo sapiens (human)
- Phosphatidylinositol Phosphate Metabolism
- Joubert syndrome
- EGF-EGFR Signaling Pathway
Biological Process
- phosphatidylinositol biosynthetic process
- neurotransmitter transport
- brain development
- learning
- synaptic vesicle priming
Molecular Function
- RNA binding
- phosphatidylinositol-3-phosphatase activity
- phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
- SH3 domain binding
- phosphatidylinositol phosphate 5-phosphatase activity
Cellular Component
- cytosol
- microtubule
- vesicle membrane
- membrane coat
- clathrin coat of coated pit
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000433931
- Coding exons
- 32
- Length
- 99291
- Individuals with no LoFs
- 125687
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 61
- Defined
- 125748
- p
- 0.000243
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.25 | 667 | 852 | 0.783 | 0.0000446 | 10473 |
| Missense (PolyPhen) | 214 | 356.61 | 0.60009 | 4369 | ||
| Synonymous | 0.409 | 295 | 304 | 0.970 | 0.0000163 | 3181 |
| Loss of Function | 6.61 | 19 | 84.5 | 0.225 | 0.00000480 | 994 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.000095 | 0.000092 | rare |
| European (Non-Finnish) | 0.00019 | 0.00019 | rare |
| South Asian | 0.00059 | 0.00059 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Phosphatase that acts on various phosphoinositides, including phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate (PubMed:27435091). Has a role in clathrin-mediated endocytosis (By similarity). Hydrolyzes PIP2 bound to actin regulatory proteins resulting in the rearrangement of actin filaments downstream of tyrosine kinase and ASH/GRB2 (By similarity). {ECO:0000250|UniProtKB:O18964, ECO:0000250|UniProtKB:Q62910, ECO:0000269|PubMed:27435091}.;
- Disease
- DISEASE: Parkinson disease 20, early-onset (PARK20) [MIM:615530]: An early-onset form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK20 is characterized by young adult-onset of parkinsonism. Additional features may include seizures, cognitive decline, abnormal eye movements, and dystonia. {ECO:0000269|PubMed:23804563, ECO:0000269|PubMed:23804577, ECO:0000269|PubMed:27496670}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 53 (EIEE53) [MIM:617389]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE53 inheritance is autosomal recessive. {ECO:0000269|PubMed:27435091}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- LoFtool
- 0.0251
- RVIS EVS
- 0.5
- RVIS percentile EVS
- 79.67
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.988
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |